Meiko Trans Co., Ltd. (XNGO:9357)
Japan · Delayed Price · Currency is JPY 1,981.00
+5.00 (0.25%)
At close: Aug 8, 2025
Inozyme Pharma Market Cap
Meiko Trans has a market cap or net worth of 59.24 billion as of August 8, 2025. Its market cap has increased by 32.43% in one year.
Market Cap
59.24B
Enterprise Value
34.89B
Revenue
82.50B
Ranking
n/a
PE Ratio
10.22
Stock Price
$1,981.00
Market Cap Chart
Since September 30, 1993, Meiko Trans's market cap has increased from 27.16B to 59.24B, an increase of 118.08%. That is a compound annual growth rate of 2.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 59.24B | 27.40% |
| Dec 30, 2024 | 46.50B | 5.91% |
| Dec 29, 2023 | 43.90B | 28.10% |
| Dec 30, 2022 | 34.27B | 4.36% |
| Dec 30, 2021 | 32.84B | -2.65% |
| Dec 30, 2020 | 33.74B | -6.68% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Toyota Motor | 36.14T |
| Mitsubishi UFJ Financial Group | 24.23T |
| Sony Group | 23.94T |
| SoftBank Group | 19.75T |
| Hitachi | 19.31T |
| Nintendo | 16.71T |
| Sumitomo Mitsui Financial Group | 14.81T |
| Fast Retailing | 14.20T |